![Foto de MARIA GLORIA](/img/nophoto.png)
MARIA GLORIA
SANCHEZ ANTOLIN
Investigadora en el periodo 1997-2020
Publicaciones (63) Publicaciones de MARIA GLORIA SANCHEZ ANTOLIN
2024
-
Hipertensión portal no cirrótica
Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 12, pp. 660-671
2023
-
Antimigration versus conventional fully covered metal stents in the endoscopic treatment of anastomotic biliary strictures after deceased-donor liver transplantation
Surgical Endoscopy, Vol. 37, Núm. 9, pp. 6975-6982
2022
-
Acute liver failure due to anti-tuberculous treatment: when you travel without medical follow-up
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 10, pp. 627-628
-
Seguimiento del trasplantado hepático en Atención Primaria
FMC: Formación Médica Continuada en Atención Primaria, Vol. 29, Núm. 5, pp. 261-267
2021
-
De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors
European Journal of Gastroenterology and Hepatology, Vol. 33, Núm. 3, pp. 399-406
-
Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation
Transplantation, Vol. 105, Núm. 3, pp. 602-607
-
Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt
Gastroenterologia y Hepatologia, Vol. 44, Núm. 9, pp. 620-627
-
Role of rapid antigen testing in population‐based sars‐cov‐2 screening
Journal of Clinical Medicine, Vol. 10, Núm. 17
-
Validez interna de una prueba rápida de detección de antígenos COVID-19 en una residencia de mayores
Semergen: revista española de medicina de familia, Núm. 5, pp. 332-336
2020
-
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
Antiviral Research, Vol. 174
-
Hemophagocytic Syndrome as Uncommon Cause of Severe Pancytopenia After Liver Transplantation
Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1500-1502
-
Immunosuppressive Treatment With mTOR Inhibitors for Malignancies After Liver Transplantation: Long-Term Survival Retrospective Analysis
Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1507-1510
-
Utility of Ethyl-Glucuronide for Evaluation of Abstinence in Patients Presenting for Liver Transplantation
Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1450-1452
2019
-
A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain
Gastroenterologia y Hepatologia, Vol. 42, Núm. 3, pp. 141-149
-
Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C
Transplantation Proceedings, Vol. 51, Núm. 1, pp. 74-76
-
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 42, Núm. 9, pp. 579-592
-
Utility of Oral Anticoagulants as Prophylaxis of Recurrent Portal Thrombosis after Liver Transplantation
Transplantation Proceedings, Vol. 51, Núm. 1, pp. 83-86
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
-
Prevalence and progression of chronic kidney disease after liver transplant: a prospective, real-life, observational, two-year multicenter study
Revista Española de Enfermedades Digestivas, Vol. 110, Núm. 9, pp. 538-543
2017
-
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
Journal of Hepatology, Vol. 67, Núm. 6, pp. 1168-1176